https://it.marketscreener.com/quotazioni/azione/SANGAMO-THERAPEUTICS-INC-10811/attualita/Sangamo-Therapeutics-presentera-i-dati-pre-clinici-della-sua-regolazione-epigenetica-per-la-neurolo-45131463/?utm_source=telegram&utm_medium=social&utm_campaign=share